MIRAGEN THERAPEUTICS INC - COM (MGEN)

CUSIP: 60463E103

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM
Total 13F shares
5,754,495
Share change
+677,677
Total reported value
$60,016,581
Price per share
$10.43
Number of holders
50
Value change
+$7,283,079
Number of buys
30
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 60463E103?
CUSIP 60463E103 identifies MGEN - MIRAGEN THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MIRAGEN THERAPEUTICS INC - COM (MGEN) as of Q4 2017

As of 31 Dec 2017, MIRAGEN THERAPEUTICS INC - COM (MGEN) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,754,495 shares. The largest 10 holders included FMR LLC, BlackRock Inc., Vanguard Group Inc, JPMORGAN CHASE & CO, STATE STREET CORP, NORTHERN TRUST CORP, Artal Group S.A., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, and BIEGEL & WALLER LLC. This page lists 50 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.